In Connecticut, specialty chemicals distributor LBB Specialties has agreed to distribute DMC Biotechnologies’ KeyPura™ fermented myo-inositol and D-chiro-inositol in the United States and Canada. Both ingredients are produced via precision fermentation and are sold into the Human Nutrition, Food, Personal Care, and Life Science markets. “This collaboration brings to market a cleaner, more sustainable, and […]
In Colorado, Toyobo Co., Ltd. recently signed a joint research and development contract related to biomanufacturing with DMC Biotechnologies Inc. The two companies aim to develop and commercialize sustainable key chemical compounds to be used as raw materials for general-purpose plastics by applying synthetic biology technologies to microorganisms. Toyobo has signed the development agreement with […]
In North Carolina, DMC Biotechnologies announced a new 9,500 square foot (880 square meter) metabolic engineering and fermentation facility in the Research Triangle Park (RTP) area of North Carolina, to support a team of scientists advancing DMC products and active collaborations. The research and development lab employs a team of metabolic engineers, precision fermentation specialists, […]
